Related references
Note: Only part of the references are listed.Burden of liver diseases in the world
Sumeet K. Asrani et al.
JOURNAL OF HEPATOLOGY (2019)
Oxidative Stress and Antioxidant Biomarkers in Clinical and Experimental Models of Non-Alcoholic Fatty Liver Disease
Ayokanmi Ore et al.
MEDICINA-LITHUANIA (2019)
Prophylactic Therapy of Silymarin (Milk Thistle) on Antituberculosis Drug-Induced Liver Injury: A Meta-Analysis of Randomized Controlled Trials
Lina Tao et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2019)
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
Naga Chalasani et al.
HEPATOLOGY (2018)
EASL Clinical Practice Guidelines: Management of alcohol-related liver disease
Mark Thursz et al.
JOURNAL OF HEPATOLOGY (2018)
The use of SAMe in chemotherapy-induced liver injury
B. Vincenzi et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)
Alcoholic Liver Disease: Alcohol Metabolism, Cascade of Molecular Mechanisms, Cellular Targets, and Clinical Aspects
Rolf Teschke
BIOMEDICINES (2018)
The interplay of IKK, NF-κB and RIPK1 signaling in the regulation of cell death, tissue homeostasis and inflammation
Vangelis Kondylis et al.
IMMUNOLOGICAL REVIEWS (2017)
A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease
Zhonge Chen et al.
LIPIDS IN HEALTH AND DISEASE (2017)
A Randomized Trial of Silymarin for the Treatment of Nonalcoholic Steatohepatitis
Chan Wah Kheong et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2017)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
Giulio Marchesini et al.
JOURNAL OF HEPATOLOGY (2016)
A Comprehensive Updated Review of Pharmaceutical and Nonpharmaceutical Treatment for NAFLD
Newaz Hossain et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2016)
Protective Role of Silymarin on Hepatic and Renal Toxicity Induced by MTX Based Chemotherapy in Children with Acute Lymphoblastic Leukemia
Adel A. Hagag et al.
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES (2016)
A double-blinded randomized controlled trial of silymarin for the prevention of antituberculosis drug-induced liver injury
Chote Luangchosiri et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2015)
The Role of Oxidative Stress and Antioxidants in Liver Diseases
Sha Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Efficacy of Lifestyle Changes in Subjects with Non-Alcoholic Liver Steatosis and Metabolic Syndrome May Be Improved with an Antioxidant Nutraceutical: A Controlled Clinical Study
Gianpaolo Sorrentino et al.
DRUGS IN R&D (2015)
Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives
Peter F. Surai
ANTIOXIDANTS (2015)
Kupffer cells: increasingly significant role in nonalcoholic fatty liver disease
Zhang Wenfeng et al.
ANNALS OF HEPATOLOGY (2014)
Obesity and non-alcoholic fatty liver disease: Disparate associations among Asian populations
Robert J. Wong et al.
WORLD JOURNAL OF HEPATOLOGY (2014)
Liver fibrosis and repair: immune regulation of wound healing in a solid organ
Antonella Pellicoro et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Glutathione synthesis
Shelly C. Lu
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2013)
Effect and the probable mechanisms of silibinin in regulating insulin resistance in the liver of rats with non-alcoholic fatty liver
Jiayin Yao et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2013)
Pathophysiology of NASH: Perspectives for a Targeted Treatment
Fabio Marra et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Acute Liver Failure
William Bernal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Alterations in Sulfur Amino Acid Metabolism in Mice Treated with Silymarin: A Novel Mechanism of Its Action Involved in Enhancement of the Antioxidant Defense in Liver
Do Young Kwon et al.
PLANTA MEDICA (2013)
Current Concepts and Management Approaches in Nonalcoholic Fatty Liver Disease
Bashar M. Attar et al.
SCIENTIFIC WORLD JOURNAL (2013)
An Assessment of Pharmacokinetics and Antioxidant Activity of Free Silymarin Flavonolignans in Healthy Volunteers: A Dose Escalation Study
Hao-Jie Zhu et al.
DRUG METABOLISM AND DISPOSITION (2013)
Legalon® SIL: The Antidote of Choice in Patients with Acute Hepatotoxicity from Amatoxin Poisoning
Ulrich Mengs et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2012)
Identification of novel mechanisms of silymarin on the carbon tetrachloride-induced liver fibrosis in mice by nuclear factor-κB bioluminescent imaging-guided transcriptomic analysis
Chia-Cheng Li et al.
FOOD AND CHEMICAL TOXICOLOGY (2012)
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
Naga Chalasani et al.
HEPATOLOGY (2012)
Silymarin suppresses hepatic stellate cell activation in a dietary rat model of non-alcoholic steatohepatitis: Analysis of isolated hepatic stellate cells
Mina Kim et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2012)
Amanita phalloides poisoning
Loren Keith French et al.
CLINICAL TOXICOLOGY (2011)
Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents The TONIC Randomized Controlled Trial
Joel E. Lavine et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
A Randomized, Controlled, Double-Blind, Pilot Study of Milk Thistle for the Treatment of Hepatotoxicity in Childhood Acute Lymphoblastic Leukemia (ALL)
Elena J. Ladas et al.
CANCER (2010)
Role of nuclear factor κB in liver health and disease
Stuart M. Robinson et al.
CLINICAL SCIENCE (2010)
The Effect of Lifestyle Changes in Non-Alcoholic Fatty Liver Disease
Elena Centis et al.
DIGESTIVE DISEASES (2010)
Alcoholic Liver Disease
Robert S. O'Shea et al.
HEPATOLOGY (2010)
Silymarin Ascending Multiple Oral Dosing Phase I Study in Noncirrhotic Patients With Chronic Hepatitis C
Roy L. Hawke et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis.
Arun J. Sanyal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Milk Thistle in Liver Diseases: Past, Present, Future
Ludovico Abenavoli et al.
PHYTOTHERAPY RESEARCH (2010)
Silymarin suppress CD4+T cell activation and proliferation: Effects on NF-κB activity and IL-2 production
Marjan Gharagozloo et al.
PHARMACOLOGICAL RESEARCH (2010)
Oxidative stress and antioxidants in hepatic pathogenesis
Hye-Lin Ha et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
NF-kappa B in liver diseases: a target for drug therapy
Pablo Muriel
JOURNAL OF APPLIED TOXICOLOGY (2009)
Silybin, a component of sylimarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells
Marco Trappoliere et al.
JOURNAL OF HEPATOLOGY (2009)
A randomized controlled trial to assess the safety and efficacy of silymarin on symptoms, signs and biomarkers of acute hepatitis
Samer S. El-Kamary et al.
PHYTOMEDICINE (2009)
Nuclear factor kappa B and hepatitis viruses
Yong-Song Guan et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2008)
Assessment of drug-drug interaction for silymarin
Johannes Doehmer et al.
TOXICOLOGY IN VITRO (2008)
An updated systematic review with meta-analysis for the clinical evidence of silymarin
Reinhard Saller et al.
FORSCHENDE KOMPLEMENTARMEDIZIN (2008)
Hepatobiliary excretion of silibinin in normal and liver cirrhotic rats
Jhy-Wen Wu et al.
DRUG METABOLISM AND DISPOSITION (2008)
Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases
A. Rambaldi et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2007)
Chronic ethanol-mediated decrease in cAMP primes macrophages to enhanced LPS-inducible NF-KB activity and TNF expression:: relevance to alcoholic liver disease
Leila Gobejishvili et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2006)
Silymarin protects against acute ethanol-induced hepatotoxicity in mice
ZY Song et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2006)
Randomised double-blinded trial evaluating silymarin for chronic hepatitis C in an Egyptian village: study description and 12-month results
MD Tanamly et al.
DIGESTIVE AND LIVER DISEASE (2004)
Silymarin retards the progression of alcohol-induced hepatic fibrosis in baboons
CS Lieber et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2003)
Primary human hepatocytes are protected against prolonged and repeated exposure to ethanol by silibinin-dihemisuccinate
JF Van Pelt et al.
ALCOHOL AND ALCOHOLISM (2003)
The use of silymarin in the treatment of liver diseases
R Saller et al.
DRUGS (2001)
Share Paper
